TrialBlood cancer journal2019

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network.

Cinnie Yentia Soekojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.